GlassScriptPhysician profile
Gene B Saylors
NPI 1215155908
$26,141.79
in general payments reported to CMS, 2019-2025
100 companies · $3,335 in 2025
The $3,335 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,219 · 2020: $4,273 · 2021: $5,082 · 2022: $3,308 · 2023: $3,162 · 2024: $3,763 · 2025: $3,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $9.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,251.14 |
| Education | $9.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $4,483.60 | 2019-2025 | Calquence, Enhertu, Lynparza |
| Novartis Pharmaceuticals Corporation | $1,443.23 | 2019-2025 | Kisqali, Piqray |
| Merck Sharp & Dohme LLC | $1,407.87 | 2019-2025 | Keytruda, Lynparza, Welireg |
| E.R. Squibb & Sons, L.L.C. | $1,231.50 | 2019-2025 | Opdivo, Opdualag, Krazati |
| Pfizer INC. | $1,097.20 | 2019-2025 | |
| Janssen Biotech, INC. | $915.50 | 2019-2025 | Darzalex, Tecvayli, Talvey |
| Genzyme Corporation | $880.12 | 2019-2024 | |
| Amgen INC. | $815.54 | 2019-2023 | Kyprolis, Blincyto, Xgeva |
| Genentech USA, INC. | $765.94 | 2019-2025 | Venclexta, Polivy, Tecentriq |
| Takeda Pharmaceuticals U.S.A., INC. | $690.12 | 2019-2025 | Alunbrig, Iclusig, Ninlaro |
| US Oncology Corporate, INC. | $637.20 | 2021-2022 | |
| Mckesson Specialty Care Distribution, LLC | $628.77 | 2019-2020 | |
| Lilly USA, LLC | $613.66 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Celgene Corporation | $599.66 | 2019-2025 | Reblozyl, Pomalyst |
| Regeneron Healthcare Solutions, INC. | $566.14 | 2019-2025 | Libtayo |
Show all 98 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $537.25 | 2020-2025 | Injectafer, Enhertu, Vanflyta |
| Eisai INC. | $480.07 | 2019-2025 | |
| Seagen INC. | $427.70 | 2019-2023 | Tukysa, Adcetris |
| Gilead Sciences, INC. | $414.80 | 2021-2025 | Trodelvy |
| Incyte Corporation | $392.63 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Epizyme, INC. | $389.69 | 2020-2021 | |
| Rigel Pharmaceuticals, INC. | $368.17 | 2019-2025 | Rezlidhia, Gavreto, Tavalisse |
| Glaxosmithkline, LLC. | $358.41 | 2020-2025 | Ojjaara, Jemperli, Zejula |
| Jazz Pharmaceuticals INC. | $341.80 | 2019-2025 | |
| Taiho Oncology, INC. | $306.00 | 2019-2025 | |
| Servier Pharmaceuticals LLC | $285.44 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $273.18 | 2019-2025 | |
| Ipsen Biopharmaceuticals, INC | $271.75 | 2019-2025 | Onivyde, Somatuline Depot |
| Abbvie INC. | $234.77 | 2021-2025 | Venclexta |
| Puma Biotechnology, INC. | $219.12 | 2019-2025 | |
| Astellas Pharma US INC | $211.79 | 2019-2025 | Xtandi, Cresemba, Vyloy |
| Karyopharm Therapeutics INC. | $181.75 | 2020-2025 | Xpovio |
| Array Biopharma INC | $176.32 | 2021-2025 | Mektovi, Braftovi, Lorbrena |
| Kite Pharma, INC. | $170.18 | 2020-2025 | Yescarta |
| Inari Medical, INC. | $167.89 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $160.37 | 2019-2025 | Gilotrif |
| Pharmacosmos Therapeutics INC. | $159.65 | 2024-2025 | Monoferric, Cosela |
| Adc Therapeutics America, INC. | $133.47 | 2021-2025 | |
| Alnylam Pharmaceuticals INC. | $123.39 | 2021-2024 | Givlaari |
| Acrotech Biopharma INC. | $122.60 | 2021-2025 | Beleodaq |
| Exelixis INC. | $109.64 | 2019-2025 | Cabometyx |
| Sobi, INC | $97.20 | 2024-2025 | |
| Pharmaessentia USA Corporation | $92.40 | 2023-2025 | Besremi |
| Foundation Medicine, INC. | $89.08 | 2020 | |
| Adaptive Biotechnologies Corporation | $83.87 | 2022-2024 | Clonoseq |
| Sanofi-Aventis U.S. LLC | $83.79 | 2019-2022 | |
| Secura Bio, INC. | $82.85 | 2020-2021 | |
| Pharmacyclics LLC, An Abbvie Company | $78.60 | 2019-2023 | Imbruvica |
| Alexion Pharmaceuticals, INC. | $78.24 | 2019-2024 | Ultomiris |
| Geron Corporation | $76.11 | 2025 | Rytelo |
| Emd Serono, INC. | $75.62 | 2022-2024 | Bavencio |
| Fennec Pharmaceuticals, INC. | $69.94 | 2024 | Pedmark |
| Stemline Therapeutics INC. | $67.48 | 2024-2025 | Orserdu, Elzonris |
| Aveo Pharmaceuticals, INC. | $66.18 | 2021-2023 | Fotivda |
| Beone Medicines USA, INC. | $65.68 | 2025 | Brukinsa |
| Iovance Biotherapeutics, INC. | $64.39 | 2025 | Amtagvi |
| Lexicon Pharmaceuticals, INC. | $59.36 | 2019 | |
| Morphosys, US INC. | $53.89 | 2022-2023 | Monjuvi |
| Legend Biotech USA INC. | $51.08 | 2025 | Carvykti |
| Beigene USA, INC. | $48.87 | 2021-2023 | Brukinsa |
| Genmab U.S., INC. | $45.12 | 2023-2025 | Epkinly |
| Kyowa Kirin, INC. | $43.92 | 2019-2025 | |
| Heron Therapeutics, INC. | $42.85 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $42.30 | 2019 | |
| Sumitomo Pharma America, INC. | $42.20 | 2023-2024 | Orgovyx |
| Syndax Pharmaceuticals, INC. | $41.48 | 2025 | |
| Azurity Pharmaceuticals, INC. | $40.63 | 2025 | Danziten |
| Deciphera Pharmaceuticals INC. | $39.48 | 2023 | Qinlock |
| Amag Pharmaceuticals, INC. | $35.83 | 2019-2021 | |
| Blue Earth Diagnostics | $35.16 | 2021-2022 | |
| Tersera Therapeutics LLC | $34.94 | 2021-2025 | Xermelo |
| Dova Pharmaceuticals | $34.31 | 2019-2021 | |
| Tesaro, INC. | $29.96 | 2019 | |
| Tempus Ai, INC | $25.95 | 2024 | Xt Cdx |
| Novocure INC. | $24.82 | 2024 | |
| Sun Pharmaceutical Industries INC. | $23.83 | 2019-2021 | |
| Forte Bio-Pharma LLC | $23.20 | 2023 | Prolate, Nalocet |
| Csl Behring | $23.04 | 2022 | |
| Verastem, INC. | $22.40 | 2019 | |
| Organon LLC | $21.44 | 2021 | |
| Medtronic, INC. | $20.62 | 2022 | |
| Cycle Pharmaceuticals INC | $19.63 | 2025 | Phyrago |
| Tolmar, INC. | $18.89 | 2023 | |
| Mirati Therapeutics, INC. | $18.68 | 2023 | Krazati |
| Immunogen, INC. | $18.66 | 2023 | Elahere |
| Spectrum Pharmaceuticals INC. | $17.66 | 2024 | Rolvedon |
| Agios Pharmaceuticals, INC. | $17.28 | 2020 | |
| Progenics Pharmaceuticals, INC. | $16.83 | 2025 | |
| Sirtex Medical INC | $16.39 | 2020 | |
| G1 Therapeutics, INC. | $16.27 | 2023 | Cosela |
| Springworks Therapeutics, INC. | $16.17 | 2024 | Ogsiveo |
| Recordati_rare_diseases_inc. | $15.48 | 2025 | Sylvant |
| Janssen Pharmaceuticals, INC | $14.98 | 2022 | |
| Acceleron Pharma, INC. | $14.35 | 2020 | |
| Coherus Oncology, INC. | $13.78 | 2021 | |
| Partner Therapeutics, INC. | $13.57 | 2020 | |
| Helsinn Therapeutics (U.S.), INC. | $11.29 | 2019 | |
| Clovis Oncology, INC. | $9.89 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
Keytruda $651Kisqali $381Libtayo $371Opdivo $329Verzenio $304Jaypirca $302Venclexta $248Tavalisse $246Rezlidhia $246Scemblix $239Lynparza $227Darzalex $218Reblozyl $213Tecvayli $211Tibsovo $203Zepzelca $195Elrexfio $183Ojjaara $182Jakafi $173Trodelvy $166Welireg $159Adcetris $157Jevtana $154Nubeqa $152Xtandi $143Tukysa $139Injectafer $136Gavreto $133Enhertu $132Alunbrig $131Monoferric $125Xofigo $124Bosulif $124Orgovyx $119Onivyde $116Talvey $114Monjuvi $109Iclusig $108Mektovi $106Braftovi $106Lenvima $105Calquence $104Yescarta $95.38Paxlovid $95.28Sarclisa $93.00Prolate $92.80Xpovio $92.44Besremi $92.40Opdualag $91.33Brukinsa $90.77Ninlaro $83.89Inlyta $81.31Talzenna $80.95Lorbrena $76.36Rytelo $76.11Retevmo $73.45Beleodaq $72.11Cabometyx $71.87Pomalyst $71.12Lonsurf $70.75Inqovi $70.75Pedmark $69.94Jemperli $69.80Zejula $69.80Epkinly $66.77Polivy $66.64Eliquis $64.90Amtagvi $64.39Givlaari $61.85Piqray $60.89Imbruvica $59.91Clonoseq $59.58Zynlonta $59.26Besponsa $59.01Gilotrif $58.90Fabhalta $58.09Synagis $57.97Kyprolis $57.14Krazati $54.06Elahere $53.05Tecentriq $52.56Pemazyre $52.34Carvykti $51.08Cosela $51.04Bavencio $50.38Orserdu $47.66Tagrisso $45.92Comirnaty $44.04Voranigo $43.41Rybrevant $42.26Ultomiris $42.04Columvi $41.74Lunsumio $41.74Emrelis $41.21Danziten $40.63Qinlock $39.48Vonjo $39.23Vanflyta $39.04Erleada $38.70Akeega $38.70
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gene Saylors listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.